Phase
Condition
Tic Disorders
Tourette's Syndrome
Autism
Treatment
Habit Reversal Training
Clinical Study ID
Ages 8-17 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Participants who meet criteria for a DSM-5-TR diagnosis of a TD will be recruited to participate in this study. Participants will be eligible for the study if they
present with at least three motor and/or vocal tics and are interested in receivingtreatment,
report experiencing a PU for each of their target tics with a minimum rating of a 4/8 on a subjective rating (i.e., the Urge Thermometer; Silverman & Albano, 1996)for each tic,
the targeted tics occur, on average, at least once per minute during a 10-minutedirect observation,
are between the ages of 8 and 17
the patient has no planned changes in medication initiation or dosage during theirstudy participation period.
Exclusion
Exclusion Criteria:
the presence of any comorbid conditions that are considered a primary treatmentconcern and/or could interfere with study participation or treatment (i.e.,unmanaged ADHD, OCD, anxiety),
have previously engaged in CBIT or HRT for more than 2 sessions,
a Yale Global Tic Severity Score of 40+ (or 20+ if they present with a primary motoror vocal tic disorder),
suspected (based on clinical presentation) that the tics are better attributed tofunctional neurological symptom disorder per DSM-5-TR criteria (APA, 2022).
Study Design
Study Description
Connect with a study center
University of Utah
Salt Lake City, Utah 84112
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.